🟢 Neumora Therapeutics is trading 8% up in pre-market with no clear company-specific catalyst identified

Neumora Therapeutics is trading at $0.75, up 7.81% after closing at $0.69 on September 21, 2026.

• No clear company-specific announcement or overnight catalyst was identified for the September 22 move.
• Recent NMRA-215 toxicology news supports planned clinical advancement but predates the move.
• Broader indexes were only modestly higher in pre-market trading.